Often, U.S. Food & Drug Administration (FDA) Advisory Panel meetings are the capstone to what is characteristically a long and arduous medical device development journey. While these meetings typically close with a voting session on a device’s approvability, recent real-world experiences demonstrate that achieving a favorable set of panel votes does not always guarantee swift FDA approval of the device under consideration.
To better understand how to effectively prepare and plan for successful Advisory Panel meetings, NAMSA is partnering with X-Talks to present the webinar, “U.S. FDA Advisory Panel Meetings: Strategies to Maximize Success” on December 7, 2017.
Join Chris Mullin, Director of Product Development Strategy (NAMSA), as he provides information on strategies that lead to success:
Time will also be allotted for Q&A